FindTrial
Sign In

A case records based retrospectively study for the clinical efficacy of cetuximab maintenance therapy in KRAS wild metastatic colorectal carcinoma

A case records based retrospectively study for the clinical efficacy of cetuximab maintenance therapy in KRAS wild metastatic colorectal carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026312
Enrollment
Unknown
Registered
2019-09-29
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Case series:cetuximab maintenance

Sponsors

1st Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
26 Years to 87 Years

Inclusion criteria

Inclusion criteria: 1. aged >=18, ECOG 0-1; 2. inoperable metastatic colorectal cancer with wild type KRAS which was confirmed by PCR/NGS; 3. with informed consent from patient or patient's family; 4. with cetuximab combined chemotherapy for metastatic colorectal cancer.

Exclusion criteria

Exclusion criteria: Not willing to be involved in.

Design outcomes

Primary

MeasureTime frame
PFS;—

Secondary

MeasureTime frame
over survival;—

Countries

China

Contacts

Public ContactXin CAI

1st Affiliated Hospital of Dalian Medical University

babydocone@126.com+86 18098876693

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026